Compositions for the treatment of infections caused by mite
The invention relates to compositions and kits for treating infections caused by the mite Demodex Spp, said compositions comprising essential oils selected from the group consisting of Eruca sativa oil, Zingiber officinale oil, and Alpinia officinarum oil and mixtures thereof incorporated into solvents and vehicles, and presented in a kit in the form of a solution, a suspension, an emulsion or a dispersion. The compositions are topically applied for the treatment of infections and disorders caused by Demodex Spp in humans.
1. An acaricidal composition for the treatment of infections and diseases caused by a mite that is a species of Demodex , which comprises a mixture of essential oils, wherein the oils are Eruca sativa mill oil, Zingiber officinale oil and Alpinia officinarum oil.
2. The composition according to claim 1 , wherein the essential oils are incorporated in an acceptable solvent.
3. The composition according to claim 2 , wherein the acceptable solvent is selected from the group consisting of: mineral oils, olive oil, decyl oleate, isopropyl myristate, polyoxyethylene glyceryl monococoate, alcohols and mixtures thereof.
4. The composition according to claim 1 , further comprising a pharmaceutically acceptable carrier.
5. The composition according to claim 3 , wherein the composition is a solution, suspension, emulsion or dispersion.
6. A method of treating a disease in a human caused by a species of Demodex , said method comprising applying topically on the human a therapeutically effective amount of the composition of claim 1 .
7. A Kit for the treatment of illnesses in humans that are caused by a mite that is a species of Demodex comprising:
(A) the composition of claim 1 , wherein the essential oils are incorporated into an acceptable solvent; and wherein the composition is a pharmaceutical solid, semisolid or liquid;
(B) an insert specifying applying said composition to the affected area and the frequency of application; and
(C) an appropriate container for the dosage forms.
8. The composition of claim 1 , wherein the composition is formulated for topical application.